Literature DB >> 17707134

Prednisolone mediated suppression of HIV-1 viral load strongly correlates with C-C chemokine CCL2: In vivo and in vitro findings.

Abdul Wahid Ansari1, Reinhold E Schmidt, Hans Heiken.   

Abstract

CCL2 (MCP-1) is a proinflammatory chemokine induced in HIV-1 infection. We have previously demonstrated a significant correlation of CCL2 gene expression with HIV-1 viremia. In this study we investigated the effect of prednisolone on CCL2 gene expression and viral load in an HIV-1-infected patient receiving high-dose prednisolone for severe uveitis. We observed a >1 log reduction of HIV-1 viral load, associated with more than hundred fold reduction of CCL2 expression at day 3 of prednisolone treatment. In vitro HIV-1 infection of PBMC demonstrated reduced HIV-1 replication in the presence of prednisolone. Flow cytometric analysis revealed 50% reduction of LTR driven GFP activity by prednisolone in GHOST cells. These findings indicate that prednisolone suppresses both HIV-1 viral load and CCL2 mRNA expression, an association which might be exploited for future anti-inflammatory therapeutic strategies in HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17707134     DOI: 10.1016/j.clim.2007.07.003

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  7 in total

1.  Selective expansion of pro-inflammatory chemokine CCL2-loaded CD14+CD16+ monocytes subset in HIV-infected therapy naïve individuals.

Authors:  A Wahid Ansari; Dirk Meyer-Olson; Reinhold E Schmidt
Journal:  J Clin Immunol       Date:  2012-09-08       Impact factor: 8.317

2.  The effect of steroid pretreatment of deceased organ donors on liver allograft function: a blinded randomized placebo-controlled trial.

Authors:  Stefan Amatschek; Julia Wilflingseder; Mario Pones; Alexander Kainz; Martin Bodingbauer; Ferdinand Mühlbacher; Robert M Langer; Zsuzsanna Gerlei; Rainer Oberbauer
Journal:  J Hepatol       Date:  2012-02-09       Impact factor: 25.083

Review 3.  Immuno-pathomechanism of liver fibrosis: targeting chemokine CCL2-mediated HIV:HCV nexus.

Authors:  A W Wahid Ansari; Reinhold E Schmidt; Esaki M Shankar; Adeeba Kamarulzaman
Journal:  J Transl Med       Date:  2014-12-10       Impact factor: 5.531

Review 4.  Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-Infection.

Authors:  A Wahid Ansari; Adeeba Kamarulzaman; Reinhold E Schmidt
Journal:  Front Immunol       Date:  2013-10-04       Impact factor: 7.561

5.  Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.

Authors:  Paul R Dominguez-Gutierrez; Angela Ceribelli; Minoru Satoh; Eric S Sobel; Westley H Reeves; Edward K L Chan
Journal:  Arthritis Res Ther       Date:  2014-01-24       Impact factor: 5.156

6.  Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder.

Authors:  Damla Tokac; Erdem Tuzun; Huseyin Gulec; Vuslat Yılmaz; Elif Sinem Bireller; Bedia Cakmakoglu; Cem Ismail Kucukali
Journal:  Psychiatry Investig       Date:  2016-09-30       Impact factor: 2.505

Review 7.  Inflammation, HIV, and Immune Quiescence: Leveraging on Immunomodulatory Products to Reduce HIV Susceptibility.

Authors:  Ross Cromarty; Derseree Archary
Journal:  AIDS Res Treat       Date:  2020-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.